Marijn Dekkers, CEO of Bayer, tells CNBC why the company's development of new drugs make him confident of reaching targets set of 2.5 billion euros in drug sales.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT